A detailed history of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H transactions in Merck & Co., Inc. stock. As of the latest transaction made, Meag Munich Ergo, Kapitalanlagegesellschaft Mb H holds 776,920 shares of MRK stock, worth $77.1 Million. This represents 2.85% of its overall portfolio holdings.

Number of Shares
776,920
Previous 757,241 2.6%
Holding current value
$77.1 Million
Previous $93.7 Million 5.89%
% of portfolio
2.85%
Previous 3.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$111.15 - $128.97 $2.19 Million - $2.54 Million
19,679 Added 2.6%
776,920 $88.2 Million
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $1.97 Million - $2.11 Million
15,896 Added 2.14%
757,241 $93.7 Million
Q1 2024

Apr 18, 2024

SELL
$113.24 - $131.95 $7.75 Million - $9.03 Million
-68,454 Reduced 8.45%
741,345 $97.8 Million
Q4 2023

Jan 19, 2024

BUY
$100.18 - $109.02 $8.86 Million - $9.64 Million
88,446 Added 12.26%
809,799 $88.3 Million
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $8.78 Million - $9.75 Million
85,301 Added 13.41%
721,353 $74.3 Million
Q2 2023

Jul 14, 2023

SELL
$108.61 - $118.38 $740,937 - $807,588
-6,822 Reduced 1.06%
636,052 $73.4 Million
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $6.78 Million - $7.56 Million
65,837 Added 11.41%
642,874 $68.4 Million
Q4 2022

Jan 19, 2023

BUY
$87.44 - $112.11 $1.22 Million - $1.56 Million
13,946 Added 2.48%
577,037 $64 Million
Q3 2022

Oct 18, 2022

BUY
$84.53 - $94.96 $6.26 Million - $7.04 Million
74,085 Added 15.15%
563,091 $48.5 Million
Q2 2022

Jul 19, 2022

BUY
$83.49 - $94.64 $9.6 Million - $10.9 Million
115,024 Added 30.76%
489,006 $44.6 Million
Q1 2022

Apr 13, 2022

BUY
$73.51 - $82.4 $1.46 Million - $1.64 Million
19,924 Added 5.63%
373,982 $31.1 Million
Q4 2021

Jan 25, 2022

BUY
$72.28 - $90.54 $25.1 Million - $31.5 Million
347,433 Added 5244.27%
354,058 $27.4 Million
Q3 2021

Oct 13, 2021

SELL
$71.68 - $78.83 $5.2 Million - $5.72 Million
-72,566 Reduced 91.63%
6,625 $498,000
Q2 2021

Jul 16, 2021

SELL
$70.31 - $77.77 $460,108 - $508,926
-6,544 Reduced 7.63%
79,191 $6.16 Million
Q1 2021

Apr 20, 2021

BUY
$68.86 - $81.11 $2.99 Million - $3.53 Million
43,482 Added 102.91%
85,735 $6.61 Million
Q4 2020

Jan 20, 2021

BUY
$71.77 - $79.65 $778,058 - $863,485
10,841 Added 34.51%
42,253 $3.41 Million
Q3 2020

Oct 20, 2020

SELL
$73.18 - $82.95 $1.04 Million - $1.18 Million
-14,214 Reduced 31.15%
31,412 $2.61 Million
Q2 2020

Jul 16, 2020

BUY
$70.42 - $80.13 $430,547 - $489,914
6,114 Added 15.47%
45,626 $3.53 Million
Q1 2020

Apr 23, 2020

SELL
$63.36 - $87.82 $2.51 Million - $3.48 Million
-39,655 Reduced 50.09%
39,512 $3.04 Million
Q4 2019

Jan 17, 2020

SELL
$77.58 - $87.54 $9.65 Million - $10.9 Million
-124,442 Reduced 61.12%
79,167 $7.21 Million
Q3 2019

Oct 29, 2019

BUY
$76.08 - $82.93 $5.56 Million - $6.06 Million
73,056 Added 55.96%
203,609 $16.8 Million
Q2 2019

Jul 17, 2019

BUY
$69.84 - $81.59 $529,736 - $618,860
7,585 Added 6.17%
130,553 $11 Million
Q1 2019

Apr 29, 2019

BUY
$69.58 - $79.36 $6.78 Million - $7.74 Million
97,484 Added 382.53%
122,968 $10.2 Million
Q4 2018

Jan 29, 2019

SELL
$65.24 - $75.71 $13 Million - $15.1 Million
-199,487 Reduced 88.67%
25,484 $1.93 Million
Q3 2018

Oct 23, 2018

BUY
$57.69 - $67.84 $247,317 - $290,830
4,287 Added 1.94%
224,971 $15.8 Million
Q2 2018

Jul 17, 2018

SELL
$50.83 - $59.72 $8.1 Million - $9.52 Million
-159,335 Reduced 41.93%
220,684 $13.4 Million
Q1 2018

May 02, 2018

BUY
$50.96 - $59.23 $11.2 Million - $13 Million
220,061 Added 137.57%
380,019 $20.8 Million
Q4 2017

Jan 26, 2018

SELL
$51.62 - $61.64 $6.13 Million - $7.31 Million
-118,671 Reduced 42.59%
159,958 $9.11 Million
Q3 2017

Nov 06, 2017

BUY
$58.67 - $63.13 $16.3 Million - $17.6 Million
278,629
278,629 $18 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.